InvestorsHub Logo
Post# of 253167
Next 10
Followers 46
Posts 4547
Boards Moderated 0
Alias Born 07/26/2010

Re: None

Tuesday, 05/17/2022 8:54:09 AM

Tuesday, May 17, 2022 8:54:09 AM

Post# of 253167
AVRO .78 - AVROBIO Reports Positive Data From Phase 1/2 Clinical Trial of Investigational Gene Therapy for Cystinosis, Including New Interim Data on Neurocognitive Measures

https://investors.avrobio.com/news-releases/news-release-details/avrobio-reports-positive-data-phase-12-clinical-trial

Any feedback from this board? Good, Bad, Indiffererent?

I own a small position and low-bidding more as one of the cashfat-biobust group.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.